Tenet Healthcare Corporation New (THC) is a publicly traded Healthcare sector company. As of May 20, 2026, THC trades at $185.73 with a market cap of $16.58B and a P/E ratio of 12.05. THC moved -1.88% today. Year to date, THC is -9.47%; over the trailing twelve months it is +11.12%. Its 52-week range spans $109.82 to $247.21. Analyst consensus is strong buy with an average price target of $248.27. Rallies surfaces THC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
THC financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. THC recently traded at $185.73. Market cap is $16.58B. P/E ratio is 12.05. Revenue is $21.31B.
| Metric | Value |
|---|---|
| Price | $185.73 |
| Market Cap | $16.58B |
| P/E Ratio | 12.05 |
| EPS | $15.61 |
| Dividend Yield | 0.00% |
| 52-Week High | $247.21 |
| 52-Week Low | $109.82 |
| Volume | 1.58M |
| Avg Volume | 0 |
| Revenue (TTM) | $21.31B |
| Net Income | $2.37B |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $21.31B | $2.37B | $15.61 |
| 2024 | $20.66B | $4.06B | $33.02 |
| 2024 | $0 | $-17.60M | $-1.15 |
| 2023 | $20.55B | $1.31B | $6.01 |
15 analysts cover THC: 0 strong buy, 14 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $248.27.